All lobbying filings

CAPITOL COUNSEL LLC

CAPITOL COUNSEL LLC filed a Q1 report for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) on April 20, 2026, reporting $50,000 in lobbying income.

Lobbying for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) · Represents pharmaceutical research and biotechnology companies

All filings by CAPITOL COUNSEL LLC · Everything PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Legislative issues related to Medicare Part B.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.